drugset / Trial / NCT00451932

A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant Patients

NCT00451932 ↗

Phase 2 Completed 303 enrolled Astellas Pharma Inc
RandomizedParallel-groupDouble-blindTreatment

Summary

A proof of concept study to evaluate the safety and effectiveness of FK778 in liver transplant patients.

Timeline

Start
2002-10
Primary completion
2005-09
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject MANITIMUS Small molecule — —

Indications

No indication recorded.